Recurrent Aortic Dissection: Observations From the International Registry of Aortic Dissection

CirculationPublished Registry-based cohort study

Authors' conclusion

Among those suffering acute aortic dissection, 5% have a history of a prior aortic dissection. Recurrent AD is strongly associated with Marfan syndrome.

Study context

Population
Patients with acute aortic dissection enrolled in IRAD
Participants
204 vs 3,624
Exposure
Recurrent aortic dissection (AD) vs initial AD
  • Recurrent ADn = 204
  • Initial ADn = 3,624reference
Outcome
Patient characteristics, interventions and outcomes, recurrent vs initial AD
Methodological detailsIRAD international registry
  • IRAD international registry

Main finding

As reported in the abstract

Patient characteristics, recurrent vs initial AD
GroupDescending aortic dimension, sentinel type ADescending aortic dimension, sentinel type B
Recurrent AD4.3 cm [3.5-5.6 cm]5.0 cm [3.9-6.0 cm]
Initial AD3.3 cm [2.9-3.7 cm]4.0 cm [3.5-4.8 cm]

Descending aortic dimension, sentinel type A

Recurrent AD4.3 cm [3.5-5.6 cm]
Initial AD3.3 cm [2.9-3.7 cm]

Descending aortic dimension, sentinel type B

Recurrent AD5.0 cm [3.9-6.0 cm]
Initial AD4.0 cm [3.5-4.8 cm]
  • Recurrent AD vs Initial AD: P < 0.001 — Marfan syndrome 21.5% vs 3.1%
  • Recurrent AD vs Initial AD: P = 0.77 — bicuspid aortic valve 3.6% vs 3.2%
  • Recurrent AD vs Initial AD: P < 0.001 — descending aortic dimension, type A
  • Recurrent AD vs Initial AD: P < 0.001 — descending aortic dimension, type B

Observational data: associations, not effects.

Further findings

Marfan syndrome as independent predictor of recurrent AD (multivariate)

ComparisonHR (95% CI)P value
Marfan syndrome8.6 (5.8–12.8)P < 0.001

Age, recurrent AD by sequence of dissection

P = 0.004

Original publication

Recurrent Aortic Dissection: Observations From the International Registry of Aortic Dissection. Circulation. Published 1 September 2016. doi:10.1161/circulationaha.115.019359

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.